QUESTCOR PHARMACEUTICALS INC's ticker is QCOR and the CUSIP is 74835Y101. A total of 324 filers reported holding QUESTCOR PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $471,000 | -9.1% | 5,089 | -36.6% | 0.01% | -20.0% |
| Q1 2014 | $518,000 | +22.7% | 8,023 | +4.0% | 0.01% | +42.9% |
| Q4 2013 | $422,000 | -35.5% | 7,718 | -31.6% | 0.01% | -41.7% |
| Q3 2013 | $654,000 | +3.0% | 11,279 | -19.4% | 0.01% | -14.3% |
| Q2 2013 | $635,000 | – | 13,991 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,296,660 | $149,800,000 | 34.05% |
| Valiant Capital Management, L.P. | 913,693 | $41,518,000 | 4.98% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 366,625 | $16,659,000 | 4.35% |
| Freshford Capital Management, LLC | 575,000 | $26,128,000 | 3.87% |
| Palo Alto Investors LP | 696,297 | $31,640,000 | 3.73% |
| RIVULET CAPITAL, LLC | 100,000 | $4,544,000 | 3.62% |
| CAPITAL MANAGEMENT CORP /VA | 190,135 | $8,640,000 | 3.59% |
| Consonance Capital Management LP | 200,000 | $9,088,000 | 3.23% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 407,400 | $18,513,000 | 2.70% |
| Freestone Capital Holdings, LLC | 268,738 | $12,211,000 | 2.50% |